Transforming the Drug Development Process: Finding the critical path to greater efficiency
Source:
SpotfireThe industry is under pressure to stem drug attrition rates and alter business strategies to account for fewer blockbuster drugs making it to market. But how do you commercialize drugs more quickly and economically while ensuring safety? This paper will explore the reasons for the need to transform the drug development process and provide a prescriptive approach to transforming your organization's clinical development process.
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


